Komori
Susmed (4263) · TargetRestated

Preparation for a confirmatory trial of an exercise therapy app for breast cancer patients

First written in FY2022-Q2. 5 of 6 entries say "Restated". Latest entry: FY2024-Q2.

6entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q2 – FY2024-Q22022: 320222023: 220232024: 12024
Same theme, other companies
Clinical Development of an Exercise Therapy App for Breast Cancer PatientsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024-Q2RestatedAnnual report

    「For the other pipelines, preparations are under way for the exercise therapy app for breast cancer patients to begin a confirmatory study.」

    The breast cancer exercise therapy app remains in the preparation stage for beginning a confirmatory study.
  2. FY2024-Q1RestatedAnnual report

    「For the other pipelines, preparations are under way for the exercise therapy app for breast cancer patients to begin a confirmatory study.」

    The exercise therapy app for breast cancer patients remains in the preparation stage for beginning a confirmatory study.
  3. FY2023RestatedAnnual report

    「The company is currently considering the protocol for future clinical trials.」

    The exercise therapy app for breast cancer patients remains at the stage of considering the protocol for a clinical trial.
  4. FY2022RestatedAnnual report

    「In 2021, the project was selected for AMED's "Advanced Research and Development and Strengthening of Development Systems for Medical Devices and Other Products" program, and the company is considering the protocol for future clinical trials.」

    The breast cancer patient app is described as being at the stage of considering the protocol for the next clinical trial.
  5. FY2022-Q3RestatedAnnual report

    「For the exercise therapy app for breast cancer patients, preparations are under way for a confirmatory study.」

    The breast cancer patient app remains in the preparation stage for a confirmatory study.
  6. FY2022-Q2First statedAnnual report

    「For the exercise therapy app for breast cancer patients, preparations are under way for a confirmatory study.」

    The breast cancer patient app is described as being in the preparation stage for proceeding to a confirmatory study.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Susmed's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Preparation for a confirmatory trial of an exercise therapy app for breast cancer patients | SUSMED,Inc. (4263) | Komori